Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Choosing between a Sep Ira and a Simple Ira can be challenging. Discover the key factors to consider for your retirement savings strategy.
15,615 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Invesco's PZA continues its long-running monthly payouts, signaling that credit quality and reinvestment strength kee...
If Klarna reveals its 2025 earnings trajectory, investors will look at growth, profitability, and risk factors more t...
A daring forecast from Goldman Sachs imagines SpaceX turning into a multi-hundred-billion-dollar revenue machine by 2...
A bold take on Tesla's future: could the Optimus robot redefine the company and its stock by 2026? This article lays ...
When the tech rally paused, AI leaders pulled back too. This guide spotlight three robust bets for long-term gains, p...
This guide helps investors decode Workiva's 2025 earnings landscape. Learn which metrics matter, how to read manageme...
Ripple merges Swell with XRPL Apex for its biggest New York conference yet, stitching together enterprise payments an...
Amazon tops Walmart in 2025 U.S. revenue, marking a historic shift toward tech-powered retail. The milestone could re...
Saia stock swooned this week after a high-profile downgrade rattled traders, even as some metrics showed resilience. ...
GLPI's Q4 2025 results show growth, margin trends, and clearer guidance for 2026. This analysis translates the number...
Nvidia CEO Jensen Huang lays out a sweeping forecast: hundreds of thousands of skilled tradespeople will be key to fu...